These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20442398)

  • 1. Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.
    Ginés S; Paoletti P; Alberch J
    J Biol Chem; 2010 Jul; 285(28):21537-48. PubMed ID: 20442398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
    J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cgamma and Shc binding sites on its receptor, TrkB.
    Williams AG; Hargreaves AC; Gunn-Moore FJ; Tavaré JM
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):505-9. PubMed ID: 9677306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
    Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
    J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TrkB-Shc Signaling Protects against Hippocampal Injury Following Status Epilepticus.
    Huang YZ; He XP; Krishnamurthy K; McNamara JO
    J Neurosci; 2019 Jun; 39(23):4624-4630. PubMed ID: 30926745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of TrkB-mediated hippocampal long-term potentiation.
    Minichiello L; Calella AM; Medina DL; Bonhoeffer T; Klein R; Korte M
    Neuron; 2002 Sep; 36(1):121-37. PubMed ID: 12367511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase.
    Ou LC; Gean PW
    Neuropsychopharmacology; 2006 Feb; 31(2):287-96. PubMed ID: 16034442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous exposure to brain-derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures.
    Barnea A; Roberts J; Croll SD
    Brain Res; 2004 Sep; 1020(1-2):106-17. PubMed ID: 15312792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
    Arany I; Faisal A; Nagamine Y; Safirstein RL
    J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ShcD interacts with TrkB via its PTB and SH2 domains and regulates BDNF-induced MAPK activation.
    You Y; Li W; Gong Y; Yin B; Qiang B; Yuan J; Peng X
    BMB Rep; 2010 Jul; 43(7):485-90. PubMed ID: 20663410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.
    Todd D; Gowers I; Dowler SJ; Wall MD; McAllister G; Fischer DF; Dijkstra S; Fratantoni SA; van de Bospoort R; Veenman-Koepke J; Flynn G; Arjomand J; Dominguez C; Munoz-Sanjuan I; Wityak J; Bard JA
    PLoS One; 2014; 9(2):e87923. PubMed ID: 24503862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses.
    Minichiello L; Casagranda F; Tatche RS; Stucky CL; Postigo A; Lewin GR; Davies AM; Klein R
    Neuron; 1998 Aug; 21(2):335-45. PubMed ID: 9728915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism.
    del Toro D; Canals JM; Ginés S; Kojima M; Egea G; Alberch J
    J Neurosci; 2006 Dec; 26(49):12748-57. PubMed ID: 17151278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.